Effect of patient positioning on carbon-ion therapy planned dose distribution to pancreatic tumors and organs at risk

被引:8
|
作者
Miki, Kentaro [1 ]
Fukahori, Mai [1 ]
Kumagai, Motoki [2 ]
Yamada, Shigeru [1 ]
Mori, Shinichiro [1 ]
机构
[1] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan
[2] Natl Canc Ctr East, Res Ctr Innovat Oncol, Particle Therapy Div, 6-5-1 Kashiwa, Chiba 2778577, Japan
关键词
Carbon ion radiotherapy; Dose distribution; Patient positioning; Pancreatic cancer; DOSIMETRIC FEASIBILITY; NORMAL TISSUE; RADIOTHERAPY; IRRADIATION; TRIAL; PRONE;
D O I
10.1016/j.ejmp.2016.12.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Pancreatic tumor treatment dose distribution variations associated with supine and prone patient positioning were evaluated. Methods: A total of 33 patients with pancreatic tumors who underwent CT in the supine and prone positions were analyzed retrospectively. Gross tumor volume (GTV), planning target volume (PTV), and organs at risk (OARs) (duodenum and stomach) were contoured. The prescribed dose of 55.2 Gy (RBE) was planned from four beam angles (0 degrees, 90 degrees, 180 degrees, and 270 degrees). Patient collimator and compensating boli were designed for each field. Dose distributions were calculated for each field in the supine and prone positions. To improve dose distribution, patient positioning was selected from supine or prone for each beam field. Results: Compared with conventional beam angle and patient positioning, D2cc of 1st- 2nd portion of duodenum (D1-D2), 3rd-4th portion of duodenum (D3-D4), and stomach could be reduced to a maximum of 6.4 Gy (RBE), 3.5 Gy (RBE), and 4.5 Gy (RBE) by selection of patient positioning. V10 of D1-D2, D3-D4, and stomach could be reduced to a maximum of 7.2 cc, 11.3 cc, and 11.5 cc, respectively. D95 of GTV and PTV were improved to a maximum of 6.9% and 3.7% of the prescribed dose, respectively. Conclusions: Optimization of patient positioning for each beam angle in treatment planning has the potential to reduce OARs dose maintaining tumor dose in pancreatic treatment. (C) 2016 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:38 / 46
页数:9
相关论文
共 50 条
  • [31] High-Dose Proton Therapy and Carbon-Ion Therapy for Stage I Nonsmall Cell Lung Cancer
    Iwata, Hiromitsu
    Murakami, Masao
    Demizu, Yusuke
    Miyawaki, Daisuke
    Terashima, Kazuki
    Niwa, Yasue
    Mima, Masayuki
    Akagi, Takashi
    Hishikawa, Yoshio
    Shibamoto, Yuta
    CANCER, 2010, 116 (10) : 2476 - 2485
  • [32] Nonuniform dose distribution in normal organs and tissues during radiation therapy of malignant tumors
    Klepper L.Ya.
    Biomedical Engineering, 1999, 33 (5) : 221 - 225
  • [33] Variation in patient position and impact on carbon-ion scanning beam distribution during prostate treatment
    Mori, S.
    Inaniwa, T.
    Miki, K.
    Tanimoto, K.
    Tajiri, M.
    Kuroiwa, D.
    Nakao, M.
    Shiraishi, Y.
    Shibayama, K.
    Tsuji, H.
    BRITISH JOURNAL OF RADIOLOGY, 2015, 88 (1051):
  • [34] Preliminary Calculation of RBE-weighted Dose Distribution for Cerebral Radionecrosis in Carbon-ion Treatment Planning
    Kase, Yuki
    Himukai, Takeshi
    Nagano, Ai
    Tameshige, Yuji
    Minohara, Shinichi
    Matsufuji, Naruhiro
    Mizoe, Junetsu
    Fossati, Piero
    Hasegawa, Azusa
    Kanai, Tatsuaki
    JOURNAL OF RADIATION RESEARCH, 2011, 52 (06) : 789 - 796
  • [35] A robustness analysis method with fast estimation of dose uncertainty distributions for carbon-ion therapy treatment planning
    Sakama, Makoto
    Kanematsu, Nobuyuki
    Inaniwa, Taku
    PHYSICS IN MEDICINE AND BIOLOGY, 2016, 61 (15): : 5818 - 5836
  • [36] Definitive Carbon-Ion Radiation Therapy for Locally Advanced Sinonasal Malignant Tumors: Subgroup Analysis of a Multicenter Study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS)
    Koto, Masashi
    Demizu, Yusuke
    Saitoh, Jun-ichi
    Suefuji, Hiroaki
    Tsuji, Hiroshi
    Okimoto, Tomoaki
    Ohno, Tatsuya
    Shioyama, Yoshiyuki
    Ikawa, Hiroaki
    Nemoto, Kenji
    Nakano, Takashi
    Kamada, Tadashi
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (02): : 353 - 361
  • [37] Monoenergetic 290 MeV/n carbon-ion beam biological lethal dose distribution surrounding the Bragg peak
    Dylan J. Buglewicz
    Austin B. Banks
    Hirokazu Hirakawa
    Akira Fujimori
    Takamitsu A. Kato
    Scientific Reports, 9
  • [38] Monoenergetic 290 MeV/n carbon-ion beam biological lethal dose distribution surrounding the Bragg peak
    Buglewicz, Dylan J.
    Banks, Austin B.
    Hirakawa, Hirokazu
    Fujimori, Akira
    Kato, Takamitsu A.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [39] Efficacy of carbon-ion radiotherapy and high-dose chemotherapy for patients with unresectable Ewing’s sarcoma family of tumors
    Shintaro Iwata
    Tsukasa Yonemoto
    Takeshi Ishii
    Kyoya Kumagai
    Reiko Imai
    Yoko Hagiwara
    Tadashi Kamada
    Shin-ichiro Tatezaki
    International Journal of Clinical Oncology, 2013, 18 : 1114 - 1118
  • [40] Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk
    Loi, Mauro
    Magallon-Baro, Alba
    Suker, Mustafa
    van Eijck, Casper
    Sharma, Aman
    Hoogeman, Mischa
    Nuyttens, Joost
    RADIOTHERAPY AND ONCOLOGY, 2019, 134 : 67 - 73